Advances of Sirolimus in the Treatment of Patients with Autoimmune Cytopenia---Review / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1667-1670, 2021.
Artigo
em Chinês
| WPRIM
| ID: wpr-922314
ABSTRACT
Autoimmune cytopenia is a general term for all hemocytopenia diseases caused by humoral or cellular immunity abnormalities, and its common immune mechanism determines the importance of immunosuppressive therapy. Sirolimus, as an immunosuppressant against of mTOR, induces immune tolerance by adjusting Treg cells, which has application prospect in the treatment of refractory autoimmune cytopenia. This article reviews the mechanism, application, and possible adverse reactions of sirolimus in the treatment of idiopathic autoimmune cytopenia.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Trombocitopenia
/
Linfócitos T Reguladores
/
Sirolimo
/
Imunossupressores
Limite:
Humanos
Idioma:
Chinês
Revista:
Journal of Experimental Hematology
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS